Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...
A 10-day dual regimen of vonoprazan and amoxicillin is noninferior to bismuth quadruple therapy for Helicobacter pylori ...
(HealthDay)—Helicobacter pylori treatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published online ...
The American Journal of Managed Care® (AJMC®): What treatment options or regimens for Helicobacter pylori exist that are not reflected in the 2017 American College of Gastroenterology (ACG) guidelines ...
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...
In elderly patients, recommendations were similar to those for the general population, however with increased monitoring; sequential therapy (amoxicillin and rabeprazole for 5 days followed by ...
Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach and small bowel. It is often symptomless, but it can increase the risk of ulcers, gastritis, and cancer, all of which can ...
(RTTNews) - RedHill Biopharma Ltd. (RDHL) Monday said the U.S. Patent and Trademark Office (USPTO) has granted new patent for Talicia indicated for the treatment of Helicobacter pylori (H. pylori) ...
A history of Helicobacter pylori infection had a modest but statistically significant association with an increased risk of colorectal cancer (CRC), including fatal CRC, a large retrospective analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results